Meditera Tibbi Malzeme Sanayi ve Ticaret Anonim Sirketi (IST:MEDTR)
27.04
-0.38 (-1.39%)
At close: Mar 27, 2026
IST:MEDTR Cash Flow Statement
Financials in millions TRY. Fiscal year is January - December.
Millions TRY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -11.73 | 73.43 | 37.35 | 114.34 | 167.7 |
Depreciation & Amortization | 176.42 | 88.31 | 75.63 | 49.83 | 11.87 |
Loss (Gain) From Sale of Assets | -17.52 | 2.24 | -127.37 | -10.94 | -1.25 |
Asset Writedown & Restructuring Costs | -0.02 | -1.52 | -13.44 | -3.24 | -4.22 |
Loss (Gain) on Equity Investments | 21.58 | -12.35 | -10.49 | -4.53 | 0.5 |
Stock-Based Compensation | - | - | - | -0.31 | - |
Provision & Write-off of Bad Debts | -0.04 | 1.13 | - | - | -0.1 |
Other Operating Activities | -75.98 | 20.15 | 18.63 | 178.69 | 24.61 |
Change in Accounts Receivable | -95.09 | 81.56 | -6.3 | -39.56 | -34.57 |
Change in Inventory | 321.29 | -30.45 | 91.21 | -91.34 | -17.09 |
Change in Accounts Payable | -142.1 | 14.17 | 20.93 | 53.93 | 24.27 |
Change in Unearned Revenue | -8.97 | -4.89 | -12.49 | 0.67 | 5.09 |
Change in Other Net Operating Assets | 267.51 | 364.66 | 727.36 | -200.38 | -140.18 |
Operating Cash Flow | 435.35 | 596.44 | 801.02 | 47.16 | 36.64 |
Operating Cash Flow Growth | -27.01% | -25.54% | 1598.51% | 28.70% | -49.98% |
Capital Expenditures | -184.56 | -191.72 | -299.56 | -90.82 | -8.92 |
Sale of Property, Plant & Equipment | 17.93 | 7.76 | 322.5 | 11.38 | 2.9 |
Divestitures | -25.27 | - | - | - | - |
Sale (Purchase) of Intangibles | -7.11 | -9.61 | -0.14 | -1.14 | -0.31 |
Other Investing Activities | 370.63 | 353.17 | 94.6 | - | - |
Investing Cash Flow | 171.62 | 159.6 | 117.4 | -80.57 | -6.33 |
Long-Term Debt Issued | - | - | 42.5 | 45 | - |
Long-Term Debt Repaid | -29.76 | -116.28 | -62.37 | -24.76 | -13.42 |
Net Debt Issued (Repaid) | -29.76 | -116.28 | -19.88 | 20.24 | -13.42 |
Issuance of Common Stock | - | 125.18 | - | - | 184.22 |
Repurchase of Common Stock | -12.31 | - | -134.02 | - | - |
Common Dividends Paid | -37.77 | -34.61 | -150 | -140 | - |
Other Financing Activities | -190.46 | -205.4 | -217.55 | -10.34 | 3.72 |
Financing Cash Flow | -270.3 | -231.1 | -521.45 | -130.11 | 174.51 |
Foreign Exchange Rate Adjustments | - | - | - | -382.61 | - |
Miscellaneous Cash Flow Adjustments | -416.36 | -439.23 | -412.96 | - | -0 |
Net Cash Flow | -79.69 | 85.7 | -16 | -546.13 | 204.82 |
Free Cash Flow | 250.79 | 404.72 | 501.46 | -43.66 | 27.72 |
Free Cash Flow Growth | -38.03% | -19.29% | - | - | -47.11% |
Free Cash Flow Margin | 8.73% | 19.32% | 23.92% | -2.74% | 7.38% |
Free Cash Flow Per Share | - | 3.40 | 4.21 | -0.37 | 0.23 |
Cash Interest Paid | - | 30.46 | 34.82 | 17.07 | 2.28 |
Cash Income Tax Paid | - | - | - | 93.56 | -21.99 |
Levered Free Cash Flow | -204.07 | -106.23 | -238.81 | -96.02 | 46.15 |
Unlevered Free Cash Flow | -187.74 | -60.13 | -191.25 | -71.22 | 54.5 |
Change in Working Capital | 342.65 | 425.06 | 820.7 | -276.68 | -162.48 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.